Cross-Market Price Comparison
| Other Listed Market | Shanghai (SSE) — 康德莱 |
|---|---|
| Other Market Stock Code | 603987 |
| H-Share Offer Price | To be extracted |
| Other Market Price | Loading... |
| Reference Exchange Rate | Loading... |
| H-Share Offer Price Premium/Discount vs Other Market | Loading... |
Company Overview
| Stock Name | Int Medical |
|---|---|
| Stock Code | 01501 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事介植入醫療器械的研發、制造及銷售，當中專注於心內介入醫療器械。 |
| Listing Date | 2019-11-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市嘉定區金園一路925號2幢 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.int-medical.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 20.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 28.3% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 416,000,000 |
Stock Connect Inclusion
| HK Market Cap | --- |
|---|
| Inclusion Pathway | None |
|---|---|
| Est. Threshold | --- |
| Analysis Result | 已纳入港股通 (港股通(A+H)) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 27.0 |
|---|---|
| First Day Open | HK$ 27.0 |
| First Day Change | 29.81% |
| First Day Volume | 32637500.0 |
| First Day Turnover | 899357000.0 |
Use of Proceeds
| Use of Proceeds | 1、凈所得款項中的約34.1%或258.5百萬港元，擬用于建設位于上海市嘉定區的研發中心及其他設施； 2、凈所得款項中的約14.4%或109.2百萬港元，將用于開發現有管線產品并將其商業化，以及進一步拓展其產品供應； 3、凈所得款項中的約13.8%或104.6百萬港元，將用于購買額外生產設備并替換現有生產設備及將生產線自動化； 4、凈所得款項中的約8.7%或65.9百萬港元，將用于擴大其分銷網絡及覆蓋范圍、與當地分銷商的合作及加大營銷力度； 5、凈所得款項中的約19.6%或148.6百萬港元，將用于為潛在戰略投資（包括收購、合伙及外部授權）提供資金； 6、凈所得款項中的約9.4%或71.2百萬港元，將用于一般企業用途和為其營運資金提供資金。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
BOCOM International (Asia) Limited CE API271
Overall Coordinators (2)
Joint Bookrunners (2)
Joint Lead Managers (2)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Worldwide Healthcare Trust PLC | 235,306,240 HKD | — | 28.28% | — | 6 months | 2020-05-08 |
Directors & Management
| Chairman | 梁棟科 |
|---|---|
| Company Secretary | 宋媛,梁瑞冰 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 上海康德萊企業發展集團股份有限公司(25.51%);梁棟科(8.30%);OrbiMed Capital LLC(6.83%);寧波懷格泰益股權投資合伙企業(有限合伙)(5.86%) |
|---|
